Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AMDL, Inc.
AMDL closes private offering of shares and warrants
May 8th, 2006
AMDL, Inc., (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced that it has conducted the closing of a combined Regulation D/Regulation S private offering of shares and warrants. The offering generated total gross proceeds of $1,812,495, exclusive of placement agent fees and expenses of $235,624. The offering consisted of the sale of an aggregate of 5,006,891 shares of AMDL common stock at $0.362 per share and three year warrants to purchase an additional 5,507,580 shares of AMDL common stock, including warrants to purchase 500,689 shares issued to the placement agents, all exercisable at $0.555 per...
Source: Biotech Week (2006-05-08)
|
